Company / Current Liabilities per Share
Edwards Lifesciences Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$3.12
FY2025
5-year range
$1.65 / $3.12
FY2021-FY2025
Trend
+24.7%
vs FY2024
Sector context
#102 of 158
Health Care
What the data says
At $3.12, Edwards Lifesciences's current liabilities per share ranks #57 of 158 in the Health Care sector. Current Liabilities per Share has increased for 5 consecutive years, from $1.43 in FY2020 to $3.12 in FY2025.
Based on SEC 10-K filings.
3.12 in FY2025 with a 5-year CAGR of +16.9%.
Increased from $1.97 to $3.12 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +22.9%
- 5-Year CAGR
- +16.9%
- 10-Year CAGR
- -
Sector benchmark
#57 of 158 in Health CareTop 35% of 158This company $3.12 Sector average $29.89
▼
-89.5% below sector average
Key checks
Key Insights
- Edwards Lifesciences's current liabilities per share has grown for 5 consecutive years.
- In FY2025, current liabilities per share increased 24.7% year-over-year.
- Ranks #102 out of 158 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.12 | +24.7% |
| FY2024 | $2.50 | +27.4% |
| FY2023 | $1.97 | +16.9% |
| FY2022 | $1.68 | +1.6% |
| FY2021 | $1.65 | +15.5% |
| FY2020 | $1.43 | -66.8% |
| FY2019 | $4.32 | +2.3% |
| FY2018 | $4.22 | -37.1% |
| FY2017 | $6.71 | +166.7% |
| FY2016 | $2.52 | -43.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026